Procurement Summary
Country: USA
Summary: Dow Melanoma Research Program Idea Award
Deadline: 14 Oct 2026
Posting Date: 22 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141810325
Document Ref. No.: HT942526MRPIA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33652100 - Antineoplastic agents
73110000 - Research services
33652000 - Antineoplastic and immunomodulating agents
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Summary: The Fiscal Year 2026 (Fy26) Melanoma Research Program (Mrp) Idea Award Supports Innovative, Exploratory, High-Risk/Potentially High-Reward Research. Novelty And Innovation Are Expected To Be Key Aspects Of The Proposed Project. By The End Of The Idea Award Funding Period, The Anticipated Outcomes Of Successful Efforts Should Establish Proof Of Principle And Obtain Preliminary Data To Secure Follow-On Funding.Distinctive Features: • Preliminary Data Are Discouraged. • After Submitting The Required Pre-Application, Investigators Must Receive An Invitation To Submit A Full Application.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy26 Mrp Ia Program Announcementmay 21, 2026 04:22 Pm Utclink To Additional Information--Closing: October 14, 2026
Posted Date: 2026-05-21 00:00:00
Funding instrument type: Grant
Documents
Tender Notice